Starting Your Journey with POEMS Syndrome

Receiving a diagnosis of POEMS syndrome often comes after months or even years of searching for answers. Because it is exceptionally rare, many patients find that their local doctors have never seen a case before, or may have initially mistaken it for more common nerve conditions ^[1]. Understanding what this diagnosis means—and why it was so hard to find—is the first step in taking control of your care.

The Rarity of POEMS

POEMS syndrome is classified as an “ultra-orphan” disease. It is estimated to affect only about 0.3 people out of every 100,000 ^[2][3]. To put that in perspective, a typical family physician might see thousands of patients over their entire career and never encounter a single person with this condition.

Because it is so uncommon, there is often a significant delay in getting the right diagnosis. Studies have shown that over half of POEMS patients are initially misdiagnosed with a more common condition called CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) ^[1]. On average, it takes about 15 months from the time symptoms first appear for a patient to receive the correct diagnosis of POEMS ^[4]. If you feel like you have been on a long and frustrating journey to get here, your experience is unfortunately very common for this disease ^[1].

Decoding the Acronym

The name “POEMS” is an acronym where each letter represents a different system in the body that the disease can affect. While not every patient will have every single symptom, the name helps doctors look for the pattern ^[5][6]:

• P: Polyneuropathy. This is often the most life-altering symptom. It refers to damage to many nerves, typically causing numbness, tingling, and weakness that starts in the feet and moves up the legs ^[1].
• O: Organomegaly. This refers to an enlarged liver, spleen, or lymph nodes ^[5].
• E: Endocrinopathy. This means the disease is affecting your hormone-producing glands, which can lead to issues with thyroid function, diabetes, or changes in sexual hormones ^[5].
• M: Monoclonal protein. This is a specific type of abnormal protein (often called an M-protein) produced by a “clone” of plasma cells in your bone marrow ^[5].
• S: Skin changes. These can include darkening of the skin, thickening, or the growth of small red spots (hemangiomas) ^[5][6].

How POEMS Works in the Body

POEMS is a paraneoplastic syndrome, which means it is a set of symptoms caused by the body’s internal reaction to a small population of abnormal cells ^[7].

In your bone marrow, there is a small group (a “clone”) of abnormal plasma cells—the cells that normally make antibodies to fight infection ^[5]. In POEMS, this clone is typically very small and slow-growing.

Instead of causing damage through sheer numbers, the POEMS plasma cells trigger the release of high levels of inflammatory signals and a specific protein called VEGF (Vascular Endothelial Growth Factor) ^[7][8].

VEGF is a signal the body usually uses to grow new blood vessels. In POEMS, the high levels of VEGF make blood vessels “leaky” ^[9]. This leakage leads to the swelling, skin changes, and organ damage seen in the disease. Most importantly, it disrupts the protective barrier around your nerves, allowing fluid and proteins to cause the nerve damage (neuropathy) that characterizes the disease ^[9][10]. While VEGF is an important biomarker and likely mediator, the exact biology is complex and not fully understood.

Distinguishing POEMS from Multiple Myeloma

It is common for patients to feel frightened when they hear words like “plasma cell disorder” or “bone marrow,” as these are often associated with multiple myeloma. POEMS is a distinct plasma-cell disorder that may overlap clinically with other plasma-cell neoplasms, but it behaves differently ^[11]:

• Clone Size: In POEMS, the abnormal plasma cells usually make up only a tiny fraction of your bone marrow, whereas in myeloma, they can take over much larger portions of the marrow ^[11].
• Bone Appearance: While myeloma typically causes “lytic” lesions (holes in the bone), POEMS often causes “sclerotic” lesions (areas where the bone becomes abnormally dense or hardened) ^[5].
• Damage Mechanism: Because POEMS is driven by an inflammatory response rather than sheer tumor mass, treatment focuses on shutting down the production of those signals ^[12][8].

Your treating team will thoroughly evaluate your bone marrow and imaging to ensure the correct diagnosis between POEMS, myeloma, and other plasma cell disorders.